Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026
Go back to Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026| DELCATH SYSTEMS (NASDAQ: DCTH) | Delayed: 12.63 +0.31 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.32 | 52 Week High | $4.72 | |||
| Open | $12.32 | 52 Week Low | $0.22 | |||
| Day High | $12.88 | P/E | N/A | |||
| Day Low | $12.22 | EPS | $-102.40 | |||
| Volume | 336,292 | |||||
